2016-03-03T00:00:00.000-05:00
chronic conditions,-0.421289
various drug classes,0.452458
drug developers,0.361361
industry intelligence solution,0.832178
regulatory factors,0.507079
syringe suppliers,0.443145
device partners,0.361361
market research,0.832178
business strategies,0.292743
device features,0.361361
major factors,0.241518
device-patient interaction,-0.211914
current generation,0.452458
therapeutic product decisions,-0.421289
practitioner offices,0.270405
advanced feature/functionality injector,0.443145
patient homes,0.270405
therapeutic markets,0.452458
Sarah Smith,0.273189
patient adherence,0.613062
correlation,-0.421289
drug developer-device manufacturer/ecosystem,0.648177
healthcare facilities,0.270405
patient self-administration,-0.421289
injection devices,0.596767
safety,0.613062
injectable products,0.613062
advanced feature/functionality injection,0.452458
injection device demand,0.241518
market status,0.741075
injectables,0.270405
key alliances,0.648177
